Lamotrigine NDC 72888-027

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-027Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0027Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72888-027-05	72888002705	500 TABLET in 1 BOTTLE (72888-027-05)Marketed from Oct 29, 2021
72888-027-60	72888002760	60 TABLET in 1 BOTTLE (72888-027-60)Marketed from Oct 29, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lamotrigine
Generic name (nonproprietary): lamotrigine
Active ingredients: Lamotrigine — 150 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Advagen Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078625
Marketing start: Oct 29, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)Dihydrofolate Reductase Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)
Identifiers: Product ID 72888-027_43efd790-7e05-d37a-e063-6294a90a4156SPL ID 43efd790-7e05-d37a-e063-6294a90a4156SPL set ID 4ca9d713-ab63-48bf-9386-29301a842e60RxCUI 198427, 198428, 198429, 282401UNII U3H27498KSUPC 0372888026008, 0372888028606, 0372888025056, 0372888027050, 0372888026053, 0372888025018, 0372888026015, 0372888027609, 0372888025001, 0372888028057
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888002705 followed by a unit qualifier and the quantity

Package 72888-0027-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 19, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Lamotrigine tablets are indicated for: Epilepsy-adjunctive therapy in patients aged 2 years and older : partial-onset seizures. primary generalized tonic-clonic seizures. generalized seizures of Lennox-Gastaut syndrome. ( 1.1 ) Epilepsy-monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug. ( 1.1 ) Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy. ( 1.2 ) Limitations of Use: Tr…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078625

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078625
Product	Strength	Form · route	Labeler	Product NDC
Lamotrigine	Lamotrigine 25 mg/1	TabletOral	Advagen Pharma Limited	72888-025
Lamotrigine	Lamotrigine 100 mg/1	TabletOral	Advagen Pharma Limited	72888-026
Lamotrigine	Lamotrigine 200 mg/1	TabletOral	Advagen Pharma Limited	72888-028